Status:
COMPLETED
Registry For Patients Treated With BeneFix In Usual Care Setting In Germany
Lead Sponsor:
Pfizer
Conditions:
Hemophilia B
Eligibility:
All Genders
Brief Summary
The purpose of this observational study is to describe the incidence of adverse events among patients treated with BeneFix® in usual health care settings in Germany.
Detailed Description
Non-interventional study: subjects to be selected according to the usual clinical practice of their physician
Eligibility Criteria
Inclusion
- Patients with hemophilia B already receiving or starting treatment with reformulated BeneFIX®.
Exclusion
- Patients with hemophilia B treated with a product other than BeneFIX®.
- Inclusion in the ongoing prospective registry of European hemophilia B patients using BeneFIX®.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00714415
Start Date
January 1 2008
End Date
October 1 2016
Last Update
October 25 2018
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Allgemeines Krankenhaus Linz, Kinderklinik
Linz, Austria, 4020
2
Sonnengesundheitszentrum
München, Bavaria, Germany, 80336
3
Werlhof-Institut für Haemostaseologie GmbH
Hanover, Lower Saxony, Germany, 30159
4
Institut für Thrombophilie und Hämostaseologie
Münster, North Rhine-Westphalia, Germany, 48143